Skip to content
Methodology
All entries for: Tr1X Inc.
September 30, 2025
Tr1X Inc.
Orphan Drug Designation
FDA orphan drug designation: prevention of acute graft versus host disease
Disease Area:
Rare Diseases
Source
Scroll to Top
